ATYPICAL ENDOGENOUS FUNGAL ENDOPHTHALMITIS CAUSED BY CANDIDA RUGOSA.
Journal
Retinal cases & brief reports
ISSN: 1937-1578
Titre abrégé: Retin Cases Brief Rep
Pays: United States
ID NLM: 101298744
Informations de publication
Date de publication:
01 Nov 2023
01 Nov 2023
Historique:
medline:
1
11
2023
pubmed:
26
3
2022
entrez:
25
3
2022
Statut:
ppublish
Résumé
The purpose of this study was to report a case of atypical endogenous fungal endophthalmitis caused by Candida rugosa , a rare species of nonalbicans Candida . This report describes a case of a 45-year-old woman who presented with a reduced visual acuity in the right eye in addition to vitreous opacity during breast cancer treatment, which was suspected as fungal endophthalmitis from medical examination and history. Various tests were performed for diagnosis. Blood test results were normal, including the blood beta-D-glucan level, and blood cultures were negative. Diagnosis could not be made using systemic computed tomography and magnetic resonance imaging results. Therefore, a lesion sample was collected by using vitrectomy. C. rugosa was identified through DNA (extracted from the lesion sample) analysis using Basic Local Alignment Search Tool. The visual acuity of the right eye improved after vitrectomy. We encountered a rare case of atypical endogenous fungal endophthalmitis caused by C. rugosa . Clinicians sometimes encounter invasive candidiasis caused by rare nonalbicans Candida species. DNA analysis using Basic Local Alignment Search Tool is effective for diagnosing such cases.
Identifiants
pubmed: 35333842
doi: 10.1097/ICB.0000000000001275
pii: 01271216-202311000-00007
pmc: PMC10597450
doi:
Substances chimiques
DNA
9007-49-2
Antifungal Agents
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
672-675Informations de copyright
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Opthalmic Communications Society, Inc.
Références
Diekema DJ, Messer SA, Boykenet LB, et al. In vitro activity of seven systemically active antifungal agents against a large global collection of rare candida species as determined by CLSI broth microdilution methods. J Clin Microbiol 2009;47:3170–3177.
Breazzano MP, Day HR Jr, Bloch KC, et al. Utility of ophthalmologic screening for patients with candida bloodstream infections: a systematic review. JAMA Ophthalmol 2019;137:698–710.
Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007;20:133–163.
Padovan AC, Melo AS, Colombo AL. Systematic review and new insights into the molecular characterization of the Candida rugosa species complex. Fungal Genet Biol 2013;61:33–41.
Colombo AL, Melo AS, Crespo Rosas RF, et al. Outbreak of Candida rugosa candidemia: an emerging pathogen that may be refractory to amphotericin B therapy. Diagn Microbiol Infect Dis 2003;46:253–257.
Peremalo T, Madhavan P, Hamzah S, et al. Antifungal susceptibilities, biofilms, phospholipase and proteinase activities in the Candida rugosa complex and Candida pararugosa isolated from tertiary teaching hospitals. J Med Microbiol 2019;68:346–354.
Breazzano MP, Day HR Jr, Bloch KC, et al. Utility of ophthalmologic screening for patients with Candida bloodstream infections: a systematic review. JAMA Ophthalmol 2019;137:698–710.
Donahue SP, Greven CM, Zuravleff JJ, et al. Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology 1994;101:1302–1309.
Ammar M, Carroll R, Kolomeyer A, et al. Clinical utility of beta-d-glucan testing for endogenous fungal chorioretinitis or endophthalmitis. Retina 2021;41:431–437.
Shimbo M, Ito N, Kadonosono K. Investigation of beta-D-glucan values in the vitreous. Nippon Ganka Gakkai Zasshi 2002;106:579–582.
Takebayashi H, Mizota A, Tanaka M. Relation between stage of endogenous fungal endophthalmitis and prognosis. Graefes Arch Clin Exp Ophthalmol 2006;244:816–820.